BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ohtake T, Itaba S, Salybekov AA, Sheng Y, Sato T, Yanai M, Imagawa M, Fujii S, Kumagai H, Harata M, Asahara T, Kobayashi S. Repetitive administration of cultured human CD34+ cells improve adenine-induced kidney injury in mice. World J Stem Cells 2023; 15(4): 268-280 [PMID: 37181001 DOI: 10.4252/wjsc.v15.i4.268]
URL: https://www.wjgnet.com/1948-0210/full/v15/i4/268.htm
Number Citing Articles
1
Anne Aries, Christine Vignon, Céline Zanetti, Aurélien Goubaud, Arthur Cormier, Anne Diederichs, Rachid Lahlil, Philippe Hénon, Ibon Garitaonandia. Development of a potency assay for CD34+ cell-based therapyScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-47079-8
2
Takayasu Ohtake, Tsutomu Sato, Toshitaka Tsukiyama, Suguru Muraoka, Ayaka Mitomo, Haruka Maruyama, Mizuki Yamano, Yasuhiro Mochida, Kunihiro Ishioka, Machiko Oka, Hidekazu Moriya, Sumi Hidaka, Haruchika Masuda, Takayuki Asahara, Shuzo Kobayashi. Preliminary evidence of renal function improvement in chronic progressive kidney disease using autologous CD34<sup>+</sup> cell therapy: A clinical trialWorld Journal of Stem Cells 2024; 16(12): 1012-1021 doi: 10.4252/wjsc.v16.i12.1012